Liposomal Oral Peptides for Immune Regulation, Tissue Repair, and Longevity in Clinical Practice Christopher Shade, PhD

In this episode of the Innovations and Clinical Implementation podcast recorded at LongevityFest 2025, hosts Dr. Lexi Gonzales and Tom Blue explore the frontier of liposomal peptide therapy with Dr. Christopher Shade—the founder and CEO of Quicksilver Scientific and an internationally recognized expert on environmental toxicants who pioneered the use of lipid-based nanoparticle delivery systems. Dr. Shade argues that "inflammaging" and endotoxemia often block the efficacy of standard hormone therapies by downregulating receptors, and he advocates for using specific liposomal peptides like BPC-157, KPV, and Thymulin to break these inflammatory cycles and reverse "fatty thymus." The conversation details how intraoral nanoliposomes utilize membrane fusion to achieve high intracellular uptake, offering practitioners a compliant, scalable method to transition from symptom-chasing "personalized medicine" to upstream "precision medicine" that rapidly seals the gut and resets immune resilience. For access to episode resources, click HERE .

You can listen to Liposomal Oral Peptides for Immune Regulation, Tissue Repair, and Longevity in Clinical Practice Christopher Shade, PhD online on Radio and Podcast. Open the player on this page to stream the available audio.

Liposomal Oral Peptides for Immune Regulation, Tissue Repair, and Longevity in Clinical Practice Christopher Shade, PhD is an episode from Redefining Medicine by A4M.

This episode is 22:30 long.

This episode was published on Mar 17, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Redefining Medicine when more episodes are available from the podcast feed.